MYDA Advisors’s VistaGen Therapeutics VTGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-50,000
Closed -$262K 111
2023
Q3
$262K Buy
+50,000
New +$262K 0.08% 73